Wasting as an independent predictor of mortality in patients with cystic fibrosis

被引:189
作者
Sharma, R
Florea, VG
Bolger, AP
Doehner, W
Florea, ND
Coats, AJS
Hodson, ME
Anker, SD [1 ]
Henein, MY
机构
[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Natl Heart & Lung Inst, Dept Clin Cardiol, London SW3 6LY, England
[2] Royal Brompton Hosp, Dept Cyst Fibrosis, London SW3 6LY, England
[3] Harefield NHS Trust, London, England
[4] Max Delbruck Ctr Mol Med, Franz Volhard Klin, Berlin, Germany
关键词
cystic fibrosis; wasting; survival;
D O I
10.1136/thorax.56.10.746
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background-Cystic fibrosis (CF) is the most common life threatening autosomal recessive disorder in the white population. Wasting has long been recognised as a poor prognostic marker in CF. Whether it predicts survival independently of lung function and arterial blood gas tensions has not previously been reported. Methods-584 patients with CF (261 women) of mean (SD) age 21 (7) years were studied between 1985 and 1996, all of whom were being followed up in a tertiary referral centre. Lung function tests, body weight, arterial blood oxygen (Pao(2)) and carbon dioxide (Paco(2)) tensions were measured. The weight was calculated as a percentage of the ideal body weight for age, height, and sex. Results-Forced expiratory volume in one second (FEV1) recorded at the start of the study was 1.8 (1.0) 1 (52 (26)% predicted FEV1), Pao(2) 9.8 (1.9) kPa, Paco(2) 5.0 (0.9) kPa, and % ideal weight 92 (18)%. During the follow up period (45 (27) months) 137 patients died (5 year survival 72%, 95% CI 67 to 73). FEV1, % predicted FEV1, Pao(2), % ideal weight (all p <0.0001), and Paco(2) (p=0.04) predicted survival. In multivariate analysis, % predicted FEV, (p <0.0001), % ideal weight (p=0.004), and Paco(2) (p=0.02) were independent predictors of outcome. Patients with > 85% ideal body weight had a better prognosis at 5 years (cumulative survival 84%, 95% CI 79 to 89) than those with less than or equal to 85% ideal weight (survival 53%, 95% CI 45 to 62), p <0.0001. Percentage predicted FEV, (area under curve 0.83; 95% CI 0.78 to 0.87) and % ideal weight (area under curve 0.74; 95% CI 0.68 to 0.79) were accurate predictors of survival at 5 years follow up (receiver-operating characteristic analysis). Conclusions-Body wasting is a significant predictor of survival in patients with,CF independent of lung function, arterial blood oxygen and carbon dioxide tensions.
引用
收藏
页码:746 / 750
页数:5
相关论文
共 50 条
  • [41] Lung transplantation in cystic fibrosis:: Perioperative mortality
    Padilla, J
    Calvo, V
    Jordá, C
    Escrivá, J
    Cerón, J
    Peñalver, JC
    García-Zarza, A
    Blasco, JPYE
    ARCHIVOS DE BRONCONEUMOLOGIA, 2005, 41 (09): : 489 - 492
  • [42] Liver disease in adult patients with cystic fibrosis: A frequent and independent prognostic factor associated with death or lung transplantation
    Chryssostalis, Ariane
    Hubert, Dominique
    Coste, Joel
    Kanaan, Reem
    Burgel, Pierre-Regis
    Desmazes-Dufeu, Nadine
    Soubrane, Olivier
    Dusser, Daniel
    Sogni, Philippe
    JOURNAL OF HEPATOLOGY, 2011, 55 (06) : 1377 - 1382
  • [43] The impact of liver disease on mortality in cystic fibrosis-A systematic review
    Sasame, Ao
    Stokes, Diarmuid
    Bourke, Billy
    Connolly, Lucy
    Fitzpatrick, Emer
    Rowland, Marion
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (02) : 202 - 211
  • [44] Cystic fibrosis mutations and associated haplotypes in Turkish cystic fibrosis patients
    Onay, T
    Zielenski, J
    Topaloglu, O
    Gokgoz, N
    Kayserili, H
    Apak, MY
    Camcioglu, Y
    Cokugras, H
    Akcakaya, N
    Tsui, LC
    Kirdar, B
    HUMAN BIOLOGY, 2001, 73 (02) : 191 - 203
  • [45] Cystic fibrosis transmembrane regulator haplotypes in households of patients with cystic fibrosis
    Furgeri, Daniela Tenorio
    Lima Marson, Fernando Augusto
    Araujo Correia, Cyntia Arivabeni
    Ribeiro, Jose Dirceu
    Bertuzzo, Carmen Silvia
    GENE, 2018, 641 : 137 - 143
  • [46] When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients
    Faro, Albert
    Goss, Christopher
    Cromwell, Elizabeth
    Elbert, Alex
    Brown, Anne W.
    Marshall, Bruce C.
    RESPIRATORY MEDICINE, 2022, 193
  • [47] First report of cystic fibrosis mutations in Libyan cystic fibrosis patients
    Fredj, Sondess Hadj
    Fattoum, Slaheddine
    Chabchoub, Abdelraouf
    Messaoud, Taieb
    ANNALS OF HUMAN BIOLOGY, 2011, 38 (05) : 561 - 563
  • [48] Nebulizers in cystic fibrosis: a source of bacterial contamination in cystic fibrosis patients?
    Costa Brzezinski, Lorena Xavier
    Riedi, Carlos Antonio
    Kussek, Paulo
    de Melo de Souza, Helena Homem
    Rosario, Nelson
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2011, 37 (03) : 341 - 347
  • [49] Ivacaftor for patients with cystic fibrosis
    Wainwright, Claire E.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2014, 8 (05) : 533 - 538
  • [50] Diets for patients with cystic fibrosis
    Wächtershäuser, A
    Bargon, JG
    Stein, J
    ERNAHRUNGS-UMSCHAU, 2002, 49 (10): : 380 - +